Showing 1 - 19 results of 19 for search 'PHARMACOECONOMICS', query time: 0.57s Refine Results
  1. 1
    Pharmacoeconomics of HIV-infection
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  2. 2
    SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH
    by R. I. Yagudina, I. V. Novikov, V. G. Serpik
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  3. 3
    Pharmacoeconomics of chronic kidney disease
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  4. 4
    Pharmacoeconomics of spastic cerebral palsy
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  5. 5
    Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
    by R. I. Yagudina, M. M. Murashko
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  6. 6
    PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
    by R. I. Yagudina, I. Yu. Zinchuk
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  7. 7
    PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
    by R. I. Yagudina, I. Yu. Zinchuk
    Published 2015-03-01
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  8. 8
    PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
    by R. I. Yagudina, V. G. Serpik
    Published 2015-03-01
    “...Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D...”
    Get full text
    Article
  9. 9
    PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
    by V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina
    Published 2015-03-01
    Subjects: “...pharmacoeconomic modeling...”
    Get full text
    Article
  10. 10
    Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
    by R. I. Yagudina, I. Yu. Zinchuk
    Published 2015-03-01
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  11. 11
    Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia
    by I. A. Metelkin, R. I. Yagudina
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  12. 12
    METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  13. 13
    PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION
    by V. G. Serpik, R. I. Yagudina
    Published 2015-03-01
    Subjects: “...pharmacoeconomic...”
    Get full text
    Article
  14. 14
    COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS
    by R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  15. 15
    METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES
    by R. I. Yagudina, I. V. Sorokovikov
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  16. 16
    COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
    by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
    Published 2015-03-01
    Subjects: “...pharmacoeconomic analysis...”
    Get full text
    Article
  17. 17
    CHIEF EDITOR`S COLUMN
    by R. I. Yagudina
    Published 2015-03-01
    Get full text
    Article
  18. 18
    HTA CORE MODEL
    by R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov
    Published 2015-03-01
    Get full text
    Article
  19. 19
    COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
    by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
    Published 2015-03-01
    “... incidence is about 1-2 cases on 100 000 men annually. Pharmacoeconomic evaluation of this pathology...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search